NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000330

Registered date:15/02/2006

Peripheral blood mononuclear cell therapy in PAD patients with intermittent claudication randamized trial

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedASO/Buerger disease
Date of first enrollment2006/01/01
Target sample size60
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)PB-MNC implantation Saline

Outcome(s)

Primary OutcomeMaximum walking distance, Pain-free walking distance, Recovery time of lower leg BP after exercise, ABPI at 6 months after treatment as compared with those before treatment
Secondary OutcomeLaser doppler image, Scintigraphy, MRI, Angiography, QOL estimation

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients with malignant diseases, severe diabetic retinopathy, or severe renal failure.

Related Information

Contact

public contact
Name Tohru Minamino
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan Japan
Telephone 043-226-2964
E-mail t_minamino@yahoo.co.jp
Affiliation Chiba University Graduate School of Medicine Department of Cardiovascular Science and Medicine
scientific contact
Name Issei Komuro
Address 1-8-1 Inohana, Chuo-ku, Chiba, Japan Japan
Telephone 043-226-2097
E-mail
Affiliation Chiba University Graduate School of Medicine Department of Cardiovascular Science and Medicine